Dr.ย Pierceย Chow
MBBS, M.Med (Surgery), FRCS (Edinburgh), FAMS (General Surgery), PhD
Senior Consultant Surgical Oncologist
corporate_fareNational Cancer Centre Singapore & SGH
Pierce Chow
MBBS, M.Med (Surgery), FRCS (Edinburgh), FAMS (General Surgery), PhD
Prof. Pierce Chow Kah Hoe is a Senior Consultant and Co-Director (Surgical) of the Comprehensive Liver Cancer Clinic at the National Cancer Centre Singapore (NCCS), and a Senior Consultant in Hepato-Pancreato-Biliary and Transplant Surgery at Singapore General Hospital. He is also a tenured Professor and Program Director of the PhD Programme in Clinical Sciences at Duke-NUS Medical School.
Prof. Chow completed his MBBS at the National University of Singapore in 1989 and subsequently attained M.Med (Surgery), FRCS from the Royal College of Surgeons of Edinburgh, FAMS in General Surgery, and a PhD. He underwent advanced clinical fellowship training in HPB surgery and liver transplantation in Australia with Professor Russell Strong. With over three decades of clinical and academic involvement in liver cancer, he leads the Programme in Translational and Clinical Liver Cancer Research at NCCS, a multi-institutional, multinational programme spanning genomics, immunology, biomarkers, and precision medicine. He has authored more than 300 peer-reviewed publications and led 12 prospective multi-centre clinical studies enrolling over 5,000 patients across 17 countries in the Asia-Pacific region.
CancerFax can coordinate medical-record review, second-opinion submissions, and consultation support for international patients seeking access to Prof. Chow's expertise at NCCS.
Why Consider Prof. Pierce Chow?
Prof. Chow brings together senior liver cancer surgical expertise, a highly productive translational research programme, and leadership of Asia-Pacific HCC clinical trials โ a combination rarely found in a single clinician.
Areas of Specialisation
Advanced liver cancer surgery, HPB oncology, transplant surgery, and translational research in hepatocellular carcinoma
Prof. Chow's clinical and research focus encompasses the full spectrum of primary liver cancer management, from surgical resection and ablation to multidisciplinary care planning, clinical trials, and precision-medicine-guided treatment approaches for hepatocellular carcinoma and biliary tract cancers.
Liver Cancer & Hepatocellular Carcinoma
Comprehensive surgical and multidisciplinary management of primary liver tumours including HCC.
- arrow_rightLiver resection for HCC and primary liver tumours
- arrow_rightCurative surgical approaches including radiofrequency ablation pathways
- arrow_rightLoco-regional therapy planning in collaboration with oncology and radiology teams
- arrow_rightBiomarker-guided treatment planning for liver cancer patients
- arrow_rightGenomics and immunology-driven research translated into clinical protocols
- arrow_rightClinical-trial eligibility evaluation for selected HCC patients
Hepato-Pancreato-Biliary & Transplant Surgery
Complex HPB oncology surgery including biliary tract and pancreatico-biliary cancers.
- arrow_rightBiliary tract cancer and cholangiocarcinoma surgery
- arrow_rightPancreatico-biliary disease management within a multidisciplinary framework
- arrow_rightComplex HPB oncology procedures at a tertiary cancer centre
- arrow_rightFellowship-trained in HPB surgery and liver transplantation
- arrow_rightTransplant surgery expertise incorporated into liver cancer care planning
Procedures Performed
Surgical oncology and HPB clinical services at NCCS and SGH
Prof. Chow performs complex liver cancer surgery and HPB oncological procedures within a multidisciplinary framework at NCCS and Singapore General Hospital. His surgical practice is integrated with translational research, clinical trial participation, and tumour-board-driven decision-making.
Liver Cancer Surgery
Complex DiseaseSurgical management of primary liver tumours including hepatocellular carcinoma and HPB malignancies.
HPB & Biliary Oncology
Complex DiseaseSurgical management of biliary tract, cholangiocarcinoma, and pancreatico-biliary cancers.
Multidisciplinary Liver Cancer Care
MultidisciplinaryIntegrated tumour board-driven care involving surgery, medical oncology, radiology, pathology, and precision medicine.
Second Opinion for Liver Cancer
Second OpinionExpert surgical second-opinion review for liver cancer and HPB malignancy cases.
Research & Publications
Translational and clinical liver cancer research โ Asia-Pacific leadership
Prof. Chow leads the Programme in Translational and Clinical Liver Cancer Research at NCCS, encompassing bench-to-bedside science in hepatocellular carcinoma. His research spans genomics, immunology, biomarkers, precision medicine, clinical trials, and novel therapeutic platforms for primary liver cancer.
Prof. Chow received the NMRC Singapore Translational Research (STaR) Investigator Award in 2025, recognising his sustained contributions to liver cancer translational research.
Education & Training
Prof. Chow trained at the National University of Singapore and obtained advanced surgical qualifications from the Royal College of Surgeons of Edinburgh, followed by fellowship training in HPB surgery and liver transplantation in Australia.
Clinical Experience
Prof. Chow has built a distinguished career spanning clinical liver cancer surgery and translational research at Singapore's leading cancer and general surgery institutions, holding senior consultant roles at NCCS and SGH concurrently with academic leadership at Duke-NUS Medical School.
Languages & International
Prof. Pierce Chow consults in English.
CancerFax can coordinate professional medical interpreter support for international patients seeking consultation at NCCS.
CancerFax can coordinate professional medical interpreter support for international patients when required.
How CancerFax Helps You Access Dr. Pierce Chow
CancerFax is a specialist cancer patient-navigation platform. We help international patients prepare structured medical summaries, assess treatment eligibility, and connect directly with Dr. Pierce Chow's team โ with full coordination from initial inquiry to consultation.
Medical Report Review
Free review of your pathology results, imaging, molecular profiling, and treatment history โ prepared as a structured clinical summary for Dr. Pierce Chow's team.
Treatment Eligibility Screening
CancerFax screens your case for eligibility for treatments and clinical programmes available through Dr. Pierce Chow before you travel, so you arrive with a clear pathway.
Case Submission
We coordinate direct case submission to Dr. Pierce Chow's department, including all documentation required for clinical review and appointment scheduling.
Appointment & Consultation Coordination
CancerFax manages appointment scheduling with Dr. Pierce Chow's team, confirming availability and aligning timelines with your travel plans.
Travel, Visa & Logistics Support
We prepare visa invitation letters, provide hospital-proximity accommodation guidance, and coordinate airport transfers for international patients.
Follow-Up & Continuity of Care
After your consultation or treatment, CancerFax facilitates communication between Dr. Pierce Chow's team and your home oncologist for seamless post-treatment follow-up.
Frequently Asked Questions About Prof. Pierce Chow
Prof. Chow specialises in liver cancer, particularly hepatocellular carcinoma (HCC). He also treats biliary tract cancer, cholangiocarcinoma, and pancreatico-biliary diseases within a multidisciplinary framework at the National Cancer Centre Singapore and Singapore General Hospital.
CancerFax can coordinate medical-record review, case preparation, and consultation support for international patients seeking access to Prof. Chow's expertise at NCCS, subject to hospital availability and case acceptance.
Submit your medical reports through CancerFax. The CancerFax team will review the documents, organise the case summary, and coordinate the next steps with NCCS, subject to availability and eligibility.
A second-opinion request can be submitted through CancerFax with the patient's imaging, pathology reports, surgical history, and relevant investigation results. Prof. Chow reviews complex liver cancer and HPB malignancy cases. The final consultation format and timeline depend on the doctor's availability at NCCS.
Prof. Chow performs liver resection, radiofrequency ablation within curative treatment pathways, loco-regional therapies for HCC, and complex HPB surgical procedures including biliary tract and pancreatico-biliary cancer surgery. He works within a multidisciplinary team at NCCS's Comprehensive Liver Cancer Clinic.
Yes. Prof. Chow serves as Protocol Chair of the Asia-Pacific Hepatocellular Carcinoma Trials Group and leads major HCC studies including PLANet and ELEGANCE at NCCS. He has led 12 prospective multi-centre studies enrolling over 5,000 patients across 17 countries and territories in the Asia-Pacific region. Trial eligibility for individual patients depends on specific study criteria.
Connect with Pierce Chow Today
Share your medical reports for a free preliminary review. Our patient coordinators will help you understand your options and arrange a direct consultation.
Medical Disclaimer: Information on this page is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making any medical decisions.